The amphetamine-induced inhibition of dopamine biosynthesis in rat striatum

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Dopamine is a crucial neurotransmitter involved in motor control, reward, and motivation.
• Understanding the developmental trajectory of dopamine synthesis is essential for comprehending neurological development and function.
• Regulatory mechanisms governing dopamine biosynthesis are key to maintaining homeostasis.

Purpose of the Study:

• To investigate the developmental timeline of dopamine biosynthesis in rat striatal synaptosomes.
• To identify the emergence of regulatory mechanisms controlling dopamine synthesis during early development.
• To examine the effect of amphetamine and haloperidol on dopamine biosynthesis in developing rats.

Main Methods:

• Measurement of dopamine biosynthetic activity in intact synaptosomes from rat striatum at different developmental stages.
• In vivo administration of amphetamine and haloperidol to assess their impact on dopamine biosynthesis.
• Analysis of the regulatory effects of drug administration on dopamine production.

Main Results:

• Dopamine biosynthetic machinery showed a 5-fold increase from neonates to adult rats.
• Full development of dopamine biosynthesis was observed between 2-3 weeks after birth.
• A regulatory mechanism inhibiting dopamine biosynthesis emerged around 2 weeks post-birth, induced by in vivo amphetamine administration.
• This amphetamine-induced inhibition was not significantly reversed by co-administration of haloperidol.

Conclusions:

• Dopamine biosynthesis undergoes significant development during early postnatal life in rats.
• A feedback regulatory mechanism for dopamine synthesis becomes functional by 2-3 weeks of age.
• Amphetamine can inhibit dopamine biosynthesis in a developmentally regulated manner, an effect not readily counteracted by haloperidol.